RecruitingNCT03525054

Semantic and Syntactic Computerized Analysis of Free Speech


Sponsor

University Hospital, Brest

Enrollment

150 participants

Start Date

May 18, 2018

Study Type

OBSERVATIONAL

Conditions

Summary

Subtle speech disorganization could be predictive of a transition to schizophrenia of ultra-high-risk patients. The aim of our longitudinal multicenter cohort study is to identify specific linguistic markers of the psychotic transition to validate a french predictive model of this transition using computerized speech analysis techniques


Eligibility

Min Age: 15 YearsMax Age: 30 Years

Plain Language Summary

Simplified for easier understanding

This trial is studying whether analyzing how young people talk — specifically the words they choose and how they form sentences — can help identify and better understand suicidal thoughts and behaviors in adolescents and young adults. **You may be eligible if...** - You are between 15 and 30 years old - You have experienced suicidal thoughts, a suicidal gesture, or suicidal behavior that has affected your emotional, social, or professional life - If you are taking medications that affect thinking, a brief pause from those medications may be scheduled before assessment **You may NOT be eligible if...** - You have a history of psychosis (serious mental illness involving a break from reality) - Your risk of self-harm is too high to be safely managed as an outpatient - Your IQ is below 70 - You have a neurological condition or major health problem - You are unable to temporarily stop your current neuroleptic medication - You decline to participate Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(3)

CHRU de Brest

Brest, France

Meunier Sophie

Caen, France

CH de SAINT ANNE

Paris, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03525054


Related Trials